Omer Yilmaz

Omer Yilmaz

Auto-generated profile, based on publicly available information

Omer Yilmaz

Department of Urology University of Health SciencesSultan Abdulhamid Han Training and Research Hospital Istanbul Turkey

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
SASerkan Akan
Serkan Akan
CECaner Ediz
Caner Ediz
ASAytac Sahin
Aytac Sahin
HTHasan Huseyin Tavukcu
Hasan Huseyin Tavukcu
AUAhmet Urkmez
Ahmet Urkmez
AVAyhan Verit
Ayhan Verit

Verified
Journal Article
Open access
PDF file
BEBilal Eryildirim
Bilal Eryildirim
EKEyüp Veli Küçük
Eyüp Veli Küçük
GAGokhan Atis
Gokhan Atis
MOMetin Ozturk
Metin Ozturk
TSTemucin Senkul
Temucin Senkul
KSKemal Sarıca
Kemal Sarıca
Aim: To assess the efficacy and safety of two different techniques (Percutaneous nephrolithotomy (PNL) vs Retrograde intrarenal surgery (RIRS)) in the management of stones in patients with horseshoe kidneys (HSK). Patients and methods: Departmental files of 88 cases with radiopaque kidney stones in horseshoe kidneys undergoing two different approaches (PNL vs RIRS) were evaluated with respect to the success and complication rates of in a retrospective manner. In addition to the factors related with the procedures (success and complication rates, additional procedures), patient and stone characteristics were all well evaluated. Findings obtained in both groups were evaluated in a comparative manner with respect to the statistical significance. Results: Stone free rates were comparable in both groups after 1-week period (81.6% PNL vs 80% RIRS). As well as 3 months evaluation (84.2% PNL and 82.0% RIRS). The percentage of the cases with residual fragments (> 4 mm) were similar in both groups and while all PNL procedures were completed in one session, mean number of RIRS sessions was higher (1.22 ± 0.05). Mean duration of the procedure was slightly higher in RIRS group and based on Clavien scoring system, despite a higher risk of Hb drop noted in patients treated with PNL, all complication rates were found to be similar in both groups. Conclusion: Our results demonstrate that of the available minimally invasive treatment alternatives, both PNL and RIRS could be safe and effective alternatives for renal stone removal in patients with HSK.

1 March 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
SASerkan Akan
Serkan Akan
CECaner Ediz
Caner Ediz
YKYunus Emre Kızılkan
Yunus Emre Kızılkan
AAAdem Alcin
Adem Alcin
HTHasan Huseyin Tavukcu
Hasan Huseyin Tavukcu
OYOmer Yilmaz
Omer Yilmaz
Aim We evaluated the COVID-19 infection threat in patients receiving intravesical BCG therapy which has immunotherapeutic effects and is of vital importance in most of the individuals with high-risk non-muscle-invasive bladder cancer (NMIBC) and investigated the need for postponement of this therapy. Methods A total of 71 patients, who were diagnosed with high-risk NMIBC and on intravesical BCG treatment regularly (induction or maintenance), were enrolled in the study. The patients were classified into two groups depending on whether they were diagnosed with COVID-19 during the pandemic period or not. Results Of 71 patients, 26 underwent a COVID-19 polymerase chain reaction test with clinical suspicion during the pandemic period. Of these 26 patients, 4 were diagnosed with COVID-19. Age of the patients, working status (working/retired), compliance with containment measures against the pandemic, number of BCG courses, adverse effects after BCG therapy and systemic immune-inflammation index, which is an inflammation-related parameter, were not different between groups (P > .05). Neutrophil/lymphocyte ratio was significantly higher in the COVID-19 positive group (P < .05). COVID-19 positivity was higher in age groups 50-64 (6.6%) and 65-80 (5.8%) years than that in similar age groups of the normal population. Conclusion Every effort should be made to administer intravesical BCG treatment in high-risk NMIBC patients even during the pandemic period. However, increased risk of COVID-19 transmission should be kept in mind and protective measures against COVID-19 for healthcare providers and patients before the procedure should be taken optimally. The procedure should be postponed in patients with lymphopenia in recent complete blood count.

17 May 2021 in Cancer Investigation
Verified
Journal Article
Closed access
SASerkan Akan
Serkan Akan
CECaner Ediz
Caner Ediz
MTM. Cihan Temel
M. Cihan Temel
FAFerhat Ates
Ferhat Ates
OYOmer Yilmaz
Omer Yilmaz
Abtract We aimed to assess the correlation between ISUP 2014 grades of needle biopsy (NB) and radical prostatectomy (RP) specimens and the parameters effecting this correlation. A total of 353 patients, who underwent a radical prostatectomy with diagnose of prostate cancer, were included in the study. Especially, the maximum percentage of core involved by cancer (MPCI) of upgraded group was significantly higher than those of correlated group and downgraded group. MPCI might be used as a preoperative value to determine risk classification and to help counsel patients with regard to treatment decision and prognosis of disease.

19 September 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
SASerkan Akan
Serkan Akan
HTHasan Hüseyin Tavukçu
Hasan Hüseyin Tavukçu
ISIbrahim Sogut
Ibrahim Sogut
ASAyşe Gökçen Sade
Ayşe Gökçen Sade
YKYunus Emre Kızılkan
Yunus Emre Kızılkan
HKHaluk Kulaksızoğlu
Haluk Kulaksızoğlu
OBJECTIVE: We aimed to determine which method gives the most consistent results between urethral monopolar cauterization and standard urethral partial ligation methods for the urethral obstruction model.METHODS: Thirty male rats were randomly divided into control, partial ligation, and monopolar cauterization groups. Six weeks after experimental procedures, the experimental groups were evaluated cystometrically, biochemically, and histologically.RESULTS: According to the cystometric results, bladder capacity, baseline bladder pressure, and compliance data of the monopolar cauterization group were higher than those of the partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). As a biochemical evaluation, malondialdehyde levels in bladder tissues of group control were higher than partial ligation and monopolar cauterization groups (p<0.05 and p<0.01, respectively). The collagen type I level of the control group was higher than the partial ligation and monopolar cauterization groups (p<0.01 and p<0.05, respectively). Collagen type III levels of the monopolar cauterization group were higher than those of the control group (p<0.01), but the Collagen type I/Collagen type III and transforming growth factor-beta levels of the monopolar cauterization group were significantly lower than those of the control group (p<0.001). As a histological evaluation (hematoxylin and eosin), fibrosis in the lamina propria was more prominent in the monopolar cauterization group than in the control group (p<0.05). In addition, the muscular thickness was higher in the monopolar cauterization group compared with control and partial ligation groups (p<0.001 and p<0.01, respectively).CONCLUSION: The needle-tipped monopolar cauterization of the posterior urethra may be the method of choice for creating a chronic infravesical obstruction model of infravesical obstruction in male rats.

1 November 2022 in Urology Research and Practice
Verified
Journal Article
Open access
STSemih Turk
Semih Turk
AYAsif Yildirim
Asif Yildirim
MIMuhammet Abdurrahim Imamoglu
Muhammet Abdurrahim Imamoglu
GAGokhan Atis
Gokhan Atis
OYOmer Yilmaz
Omer Yilmaz
MÇMehmet Çağlar Çakıcı
Mehmet Çağlar Çakıcı
Objective: Diagnostic ureterorenoscopy is used to identify upper tract urothelial cancer before radical nephroureterectomy, especially for uncertain lesions in imaging modalities or urine cytology. However, diagnostic ureterorenoscopy can potentially cause intravesical tumor spillage and can increase intravesical recurrence rates. We aimed to investigate the impact of diagnostic ureterorenoscopy before radical nephroureterectomy, with and without biopsy, on intravesical recurrence rates of patients with upper tract urothelial cancer. Material and methods: Patients with localized upper tract urothelial cancer from 8 different tertiary referral centers, who underwent radical nephroureterectomy between 2001 and 2020, were included. Three groups were made: no URS (group 1); diagnostic ureterorenoscopy without biopsy (group 2); and diagnostic ureterorenoscopy with biopsy (group 3). Intravesical recurrence rates and survival outcomes were compared. Univariate and multivariate Cox regression analyses were performed to determine the factors that were associated with intravesical recurrence-free survival. Results: Twenty-two (20.8%), 10 (24.4%), and 23 (39%) patients experienced intravesical recurrence in groups 1, 2, and 3, respectively (P=.037) among 206 patients. The 2-year intravesical recurrence-free survival rate was 83.1%, 82.4%, and 69.2%, for groups 1, 2, and 3, respectively (P=.004). Cancer-specific survival and overall survival were comparable (P=.560 and P=.803, respectively). Diagnostic ureterorenoscopy+biopsy (hazard ratio: 6.88, 95% CI: 2.41-19.65, P < .001) was the only independent predictor of intravesical recurrence in patients with upper tract urothelial cancer located in the kidney, according to tumor location. Conclusion: Diagnostic ureterorenoscopy+biopsy before radical nephroureterectomy significantly increased the rates of intravesical recurrence in tumors located in kidney. This result suggests tumor spillage with this type of biopsy, so further studies with different biopsy options or without biopsy can be designed. Cite this article as: Culpan M, Cakici MC, Keser F, et al. Biopsy with ureterorenoscopy before radical nephroureterectomy is associated with increased intravesical recurrence in urothelial cancer located in the kidney. Turk J Urol. 2022;48(6):431-439.